Million from loss on change in fair value less cost to sale of biological assets, resulted from decreased fair price of fattening pigs from the end of Q2/2019 to Q3/2019. Financial Cost Financial cost in
less land expenses and legal fee. Loss from change in fair value of biological assets : The subsidiary (UPOIC) realized loss from change in fair value of biological assets of Baht 4.6 million (Q1/2019
for rent and Baht 5.4 Million from gain on change in fair value less cost of sale of biological assets. Financial Cost Financial cost in Q2/2020 was Baht 8.1 Million had decreased by Baht 0.4 Million or
เนอร์จี้ จำกัด (มหาชน) กรุณาระบุเงื่อนไขในการค้นหา ค้นหาบริษัท ACE: บริษัท แอ๊บโซลูท คลีน เอ็นเนอร์จี้ จำกัด (มหาชน) JSP: JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED PEACE: บริษัท
SERVICES PUBLIC COMPANY LIMITED Filing FinancialStatement 56-1 56-2 Ranking JSP JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED Filing FinancialStatement 56-1 56-2 Ranking JUBILE JUBILEE
expenses control. Other Transaction In year 2017 there were Baht 6.2 million from loss on change in fair value less costs to sell of biological assets, Baht 26.3 million and Baht 16.2 million from new office
receivable 87.00 4.25% - - Investment in associated company 272.33 13.32% 286.20 17% Property, plant and equipment 791.98 38.72% 871.72 52% Right-of-used 213.73 10.45% - - Biological assets – dairy cow 48.07
81.47 4% 83.74 4% Investment in associated company 230.00 11% 235.09 12% Property, plant and equipment 776.29 38% 803.45 40% Right-of-used 198.67 10% 214.69 11% Biological assets – dairy cow 50.31 2
% Property, plant and equipment 765.92 38% 803.45 39% Right-of-used 193.53 10% 214.69 11% Biological assets – dairy cow 48.91 2% 46.25 2% Others 46.76 2% 40.33 1% Total assets 2,034.21 100% 2,018.34 100% Total
% Lease receivable 76.30 4% 75.88 4% Investment in associated company 203.78 10% 210.47 11% Property, plant and equipment 743.60 37% 757.69 39% Right-of-used 164.29 8% 179.07 9% Biological assets – dairy